Epstein Secrets

ily offices with a global presence and long-term investment horizon" and formed specifically to invest in Editas. CEO Katrine Bosley confirmed that Gates is one of the individuals investing in Editas alongside Nikolic. To be clear, while this is a significant round, it's not even close to the largest

s, Jennison Associates, Khosla Ventures, EcoR1 Capital, Casdin Capital, Omega Funds, Cowen Private Investments, and Alexandria Venture Investments. Editas' founding VC backers—Flagship Ventures Polaris Partners and Third Rock Ventures-also pitched in, as did Partners Innovation Fund. Nikolic, who is j

d Nikolic's relationship isn't clear, but a source told Bloomberg that Nikolic funded more than a dozen gene-editing businesses after splitting from Gates in 2014 and controlled a $42 million stake in one gene company, Editas Medicine Inc. Nikolic, 49, was excited about financial advice that Epstein,

xcited about financial advice that Epstein, a former hedge-fund manager who was obsessed with genetic research, shared with private bankers ahead of Editas' public offering, the source told Bloomberg. Nikolic was part of a broad network that overlapped with Epstein, Nikolic's spokeswoman said. A rep fo

d Nikolic's relationship isn't clear, but a source told Bloomberg that Nikolic funded more than a dozen gene-editing businesses after splitting from Gates in 2014 and controlled a $42 million stake in one gene company, Editas Medicine Inc. Nikolic, 49, was excited about financial advice that Epstein,

xcited about financial advice that Epstein, a former hedge-fund manager who was obsessed with genetic research, shared with private bankers ahead of Editas' public offering, the source told Bloomberg. Nikolic was part of a broad network that overlapped with Epstein, Nikolic's spokeswoman said. A rep fo